RETA
Price
$172.35
Change
+$0.03 (+0.02%)
Updated
Sep 25, 11:10 AM EST
43 days until earnings call
TSVT
Price
$3.23
Change
+$0.08 (+2.54%)
Updated
Sep 25, 12:26 PM EST
65 days until earnings call

Analysis and predictions RETA vs TSVT

Header iconRETA vs TSVT Comparison
Open Charts RETA vs TSVTBanner chart's image
Reata Pharmaceuticals
Price$172.35
Change+$0.03 (+0.02%)
Volume$1.15K
CapitalizationN/A
2seventy bio
Price$3.23
Change+$0.08 (+2.54%)
Volume$4.37K
CapitalizationN/A
View a ticker or compare two or three
RETA vs TSVT Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
RETA vs. TSVT commentary
Sep 25, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RETA is a Hold and TSVT is a Hold.

COMPARISON
Comparison
Sep 25, 2023
Stock price -- (RETA: $172.32 vs. TSVT: $3.15)
Brand notoriety: RETA and TSVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RETA: 63% vs. TSVT: 87%
Market capitalization -- RETA: $6.56B vs. TSVT: $158.96M
RETA [@Biotechnology] is valued at $6.56B. TSVT’s [@Biotechnology] market capitalization is $158.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RETA’s FA Score shows that 0 FA rating(s) are green whileTSVT’s FA Score has 1 green FA rating(s).

  • RETA’s FA Score: 0 green, 5 red.
  • TSVT’s FA Score: 1 green, 4 red.
According to our system of comparison, RETA is a better buy in the long-term than TSVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RETA’s TA Score shows that 3 TA indicator(s) are bullish while TSVT’s TA Score has 3 bullish TA indicator(s).

  • RETA’s TA Score: 3 bullish, 3 bearish.
  • TSVT’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both RETA and TSVT are a good buy in the short-term.

Price Growth

RETA (@Biotechnology) experienced а +0.19% price change this week, while TSVT (@Biotechnology) price change was -22.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.05%. For the same industry, the average monthly price growth was +21.89%, and the average quarterly price growth was +34.13%.

Reported Earning Dates

RETA is expected to report earnings on Nov 07, 2023.

TSVT is expected to report earnings on Nov 29, 2023.

Industries' Descriptions

@Biotechnology (-3.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for RETA with price predictions.
OPEN
A.I.dvisor published
a Summary for TSVT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RETA($6.57B) has a higher market cap than TSVT($159M). RETA YTD gains are higher at: 353.593 vs. TSVT (-66.382). RETA has higher annual earnings (EBITDA): -45.94M vs. TSVT (-185.86M). RETA has more cash in the bank: 330M vs. TSVT (283M). RETA has less debt than TSVT: RETA (166M) vs TSVT (264M). TSVT has higher revenues than RETA: TSVT (147M) vs RETA (23.5M).
RETATSVTRETA / TSVT
Capitalization6.57B159M4,129%
EBITDA-45.94M-185.86M25%
Gain YTD353.593-66.382-533%
P/E RatioN/AN/A-
Revenue23.5M147M16%
Total Cash330M283M117%
Total Debt166M264M63%
FUNDAMENTALS RATINGS
RETA: Fundamental Ratings
RETA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RETATSVT
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 6 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 27 days ago
80%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
71%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EDF4.400.12
+2.80%
Virtus Stone Harbor Emerging Markets Income Fund
SDIV22.160.10
+0.45%
Global X SuperDividend™ ETF
VEU52.630.19
+0.36%
Vanguard FTSE All-Wld ex-US ETF
GRPM85.80-0.17
-0.20%
Invesco S&P MidCap 400® GARP ETF
UCC29.60-0.96
-3.14%
ProShares Ultra Consumer Discretionary

RETA and

Correlation & Price change

A.I.dvisor indicates that over the last year, RETA has been loosely correlated with SRPT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RETA jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RETA
1D Price
Change %
RETA100%
+0.09%
SRPT - RETA
44%
Loosely correlated
+0.32%
NTLA - RETA
41%
Loosely correlated
-3.40%
MDGL - RETA
39%
Loosely correlated
-3.87%
TSVT - RETA
36%
Loosely correlated
+0.32%
AVIR - RETA
36%
Loosely correlated
+0.63%
More

TSVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSVT has been loosely correlated with SRNEQ. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if TSVT jumps, then SRNEQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSVT
1D Price
Change %
TSVT100%
+0.32%
SRNEQ - TSVT
59%
Loosely correlated
-2.54%
MDGL - TSVT
50%
Loosely correlated
-3.87%
NTLA - TSVT
45%
Loosely correlated
-3.40%
CRSP - TSVT
44%
Loosely correlated
-1.24%
ALLO - TSVT
43%
Loosely correlated
-1.88%
More